"All you get is a plain brown envelope, " says Jeffrey Kindler, Pfizer's vice chairman.
Chief Executive Jeffrey Kindler has made one of his most important and much-awaited decisions: He reorganized his research labs.
Read is taking over for Jeffrey Kindler, who ran the company for four years and retired suddenly in November.
Pfizer Chief Executive Jeffrey Kindler announced "an important decision" Thursday morning, in the press release that carried Pfizer's third-quarter financial results.
Hillary Clinton, whose health plan the industry reviled a decade ago, is getting big pharma money, including from Pfizer Chairman Jeffrey Kindler.
This comes a week after Chairman and CEO Jeffrey Kindler left abrubtly.
FORBES: After Hours: Amgen's Drug May Help Patients Live Longer
After six months, Pfizer Chief Executive Jeffrey Kindler has made one of his most important and much-awaited decisions: He reorganized his research labs.
"This is a risky business, and we all know that, " says Chief Executive Jeffrey Kindler, who's been in the job just over a year.
His replacement, Jeffrey Kindler, has managed a 3% stock bump since he took the job, even though he oversold its cholesterol drug torcetrapib, a colossal failure.
Pfizer Chief Executive Jeffrey Kindler is making bold moves that seem to constitute a reversal of the strategies of his predecessor, Hank McKinnell .
The extra time gives Pfizer Chief Executive Jeffrey Kindler breathing room in which to convince investors that his company can deliver new drugs to make up for patent losses.
Jeffrey Kindler, who became chairman and chief executive of Pfizer suddenly and unexpectedly a little more than four years ago, is now retiring suddenly and unexpectedly.
Taking over two years ago with a pledge to transform Pfizer, Chief Executive Jeffrey Kindler has cut 10, 000 jobs and put new executives in charge of research, finance and global marketing.
Pfizer chief Jeffrey Kindler, who came to Pfizer from McDonald's and has helmed the company for only a year, is turning to outsiders to try to figure out how to fix the world's largest drug giant.
The world's largest drug firm's new chief executive, Jeffrey Kindler , has said he wants to "transform" the company and took the unprecedented step of cutting some 2, 000 jobs from the drug giant's 10, 000-strong U.S. sales force.
If Pfizer boss Jeffrey Kindler can keep his ship stable, it will go a long way toward proving that Pfizer's great size, flexibility and newfound willingness to change may keep things from getting worse for the drug giant.
Pfizer chief Jeffrey Kindler, who came to Pfizer from McDonald's (nyse: MCD - news - people ) and has helmed the company for only a year, is turning to outsiders to try to figure out how to fix the world's largest drug giant.
Both Deutsche Bank (nyse: DB - news - people ) analyst Barbara Ryan and Kelly say it is worth betting on Pfizer Chief Executive Jeffrey Kindler 's planned transformation, especially since Pfizer pays a healthy dividend that was hiked by 21% this year.
应用推荐